VICIS, a rapidly growing sports technology company, is targeting a $25M - $35M Series C financing. VICIS was founded in mid-2013 to address the sports-related head health issue in contact sports, beginning with football. It is now expanding into other sports and categories, seeking capital to support its rapid growth.
The company's technology was used by hundreds of professional and elite NCAA players in its inaugural season. Feedback has been excellent. Professional athletes are some of the Company's strongest advocates.
We are currently only accepting capital from investors that are referred to us through existing relationships.